OFM
KMTS

Omega Fund Management’s Kestra Medical Technologies KMTS Stock Holding History

Omega Fund Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.4M Sell
1,022,149
-351,442
-26% -$8.28M 12.49% 4
2025
Q4 		$36.4M Sell
1,373,591
-272,302
-17% -$7.01M 12.71% 5
2025
Q3 		$39.1M Hold
1,645,893
– – 17.59% 1
2025
Q2 		$27.3M Sell
1,645,893
-150,000
-8% -$3.27M 17.67% 2
2025
Q1 		$44.8M Buy
+1,795,893
New +$41.3M 26.41% 1

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Omega Fund Management's KMTS Position: Q1 2026 in Review

Omega Fund Management reduced its Kestra Medical Technologies (KMTS) stake by 26% in Q1 2026, selling an estimated $8.28M and leaving 1,022,149 shares worth $20.4M. The position accounts for 12.49% of the portfolio, ranked #4.

Omega Fund Management first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $44.8M in Q1 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Omega Fund Management held 1,022,149 shares of Kestra Medical Technologies worth $20.4M as of Q1 2026.
  • Omega Fund Management sold 351,442 Kestra Medical Technologies shares in Q1 2026, an estimated $8.28M.
  • Kestra Medical Technologies made up 12.49% of Omega Fund Management's portfolio in Q1 2026, its #4 holding.
  • Omega Fund Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • Omega Fund Management's Kestra Medical Technologies position peaked at $44.8M in Q1 2025.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Omega Fund Management's 13F filing for Q1 2026, filed 15 May 2026.